NASDAQ: DMAC

Analyst Insights

DiaMedica Therapeutics Inc (DMAC) with a beta value of 1.12 appears to be a promising investment opportunity.

Sana Meer

DiaMedica Therapeutics Inc (NASDAQ: DMAC) kicked off on Monday, down -7.67% from the previous trading day, before settling in for ...

Top Picks

6.43% volatility in DiaMedica Therapeutics Inc (DMAC) last month: This is a red flag warning

Zack King

On Monday, DiaMedica Therapeutics Inc (NASDAQ: DMAC) opened higher 8.09% from the last session, before settling in for the closing ...

News Daemon
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.